Delivery Order SPE2DB20D3505-SPE2DB22FT6Q8

Award Date 4/8/22
Potential Completion Date 4/11/22
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,785.60 firm fixed-price delivery order is for the supply of the medication Estring 2 mg vaginal rings. The contract is not designated with a set-aside requirement, indicating open competition. It is a delivery order that is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc....
This federal contract award is for the delivery of ESTRING 2 MG VAGINAL RINGS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $5,273.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
This federal contract award is for the delivery of Estring 2 mg vaginal rings to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,576.33 and a completion date of June 1, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ESTRING 2 MG VAGINAL RINGS. The contract, valued at $1,398.31, is a Firm Fixed Price Delivery Order with a completion date of June 6, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS52D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,941.32 firm fixed-price delivery order is for the supply of 4560193930 - ESTRING 2 MG VAGINAL RINGS. The contract has an ultimate completion date of March 9, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,153.75 firm fixed price delivery order is for ESTRING 7.5 MCG/DAY (2MG) RINGS, a medical product used for treatment. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This delivery order contract, valued at $2,458.12, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Estring 2 mg vaginal rings. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as a...
This federal contract award, valued at $17,417.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTRING 2 MG VAGINAL RINGS, a pharmaceutical product, with a completion date of June 30, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.72 firm fixed-price delivery order is for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a vaginal estrogen medication. The contract has a period of performance through November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,325.06, is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB22FT6Q8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.60 firm fixed-price delivery order is for the supply of the vaginal ring medication ESTRING 2 MG.

The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Cencora, Inc. also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These long-term IDCs enable the government to efficiently procure essential pharmaceutical and medical supplies through a streamlined contracting mechanism.

Generated 2/27/25, 12:14 PM